l-arabinose

Small moleculeexperimental

Arabinose is an aldopentose – a monosaccharide containing five carbon atoms, and including an aldehyde (CHO) functional group. — Wikipedia

Clinical trial activity

7 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Sep 1, 2005 (NCT00302302)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

O[C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1O
Mol. weight
150.13 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • iqp-vv-102
  • l-arabinose
  • l-arabinose

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01681069Phase 3Oct 1, 2012InQpharm Group
NCT01801540N/ADec 1, 2010University of Copenhagen
NCT01039662N/ADec 1, 2009Hiroshima University, Unitika Ltd.
NCT00880646N/AMar 1, 2009Hiroshima University, Unitika Ltd.
NCT01107431N/ADec 1, 2008Georgetown University, Integrative Health Technologies
NCT01957098N/AOct 1, 2006Danisco, University of Copenhagen
NCT00302302Phase 1Sep 1, 2005Danisco, Royal Veterinary and Agricultural University, Denmark, University of Copenhagen
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of CopenhagenAcademic/Hospital3322005
DaniscoFor profit2022005
Hiroshima UniversityAcademic/Hospital2212009
Unitika Ltd.For profit2012009
Georgetown UniversityAcademic/Hospital1012008
InQpharm GroupFor profit1112012
Integrative Health TechnologiesFor profit1112008
Royal Veterinary and Agricultural University, DenmarkAcademic/Hospital1012005
8 organizations
Page 1 / 1